Q3 EPS Estimates for SBC Medical Group Reduced by Sidoti Csr

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Research analysts at Sidoti Csr decreased their Q3 2025 earnings per share estimates for SBC Medical Group in a research report issued on Tuesday, May 20th. Sidoti Csr analyst A. Shah now anticipates that the company will earn $0.13 per share for the quarter, down from their prior estimate of $0.14. The consensus estimate for SBC Medical Group’s current full-year earnings is $5.02 per share. Sidoti Csr also issued estimates for SBC Medical Group’s Q4 2025 earnings at $0.13 EPS, Q1 2026 earnings at $0.14 EPS, Q2 2026 earnings at $0.14 EPS, Q3 2026 earnings at $0.14 EPS, Q4 2026 earnings at $0.16 EPS and FY2026 earnings at $0.58 EPS.

SBC Medical Group (NASDAQ:SBC) last announced its quarterly earnings results on Thursday, May 15th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.10. The business had revenue of $47.33 million for the quarter, compared to analysts’ expectations of $51.52 million.

SBC Medical Group Price Performance

SBC Medical Group stock opened at $3.55 on Wednesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.79 and a quick ratio of 2.76. SBC Medical Group has a fifty-two week low of $2.62 and a fifty-two week high of $12.50. The stock has a 50-day simple moving average of $3.50 and a 200-day simple moving average of $4.83.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.